Clearwater Capital Advisors’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,337
| Closed | -$209K | – | 160 |
|
|
2023
Q4 | $209K | Buy |
+3,337
| New | +$209K | 0.02% | 146 |
|
|
2022
Q4 | – | Sell |
-3,233
| Closed | -$211K | – | 162 |
|
|
2022
Q3 | $211K | Buy |
+3,233
| New | +$211K | 0.03% | 144 |
|
|
2022
Q1 | – | Sell |
-2,921
| Closed | -$221K | – | 171 |
|
|
2021
Q4 | $221K | Buy |
2,921
+359
| +14% | +$27.2K | 0.02% | 157 |
|
|
2021
Q3 | $287K | Buy |
2,562
+356
| +16% | +$39.9K | 0.03% | 140 |
|
|
2021
Q2 | $357K | Sell |
2,206
-5
| -0.2% | -$809 | 0.04% | 119 |
|
|
2021
Q1 | $269K | Buy |
2,211
+863
| +64% | +$105K | 0.03% | 137 |
|
|
2020
Q4 | $206K | Buy |
+1,348
| New | +$206K | 0.03% | 147 |
|